122 related articles for article (PubMed ID: 12972336)
1. Long-term stabilization of recombinant human interferon alpha 2b in aqueous solution without serum albumin.
Ruiz L; Reyes N; Duany L; Franco A; Aroche K; Hardy Rando E
Int J Pharm; 2003 Oct; 264(1-2):57-72. PubMed ID: 12972336
[TBL] [Abstract][Full Text] [Related]
2. Long-term stabilization of a new freeze-dried and albumin-free formulation of recombinant human interferon alpha 2b.
Ruiz L; Reyes N; Sotolongo J; Aroche K; Aldana R; Báez R; Hardy E
PDA J Pharm Sci Technol; 2006; 60(1):72-8. PubMed ID: 17089680
[TBL] [Abstract][Full Text] [Related]
3. Influence of packaging material on the liquid stability of interferon-alpha2b.
Ruiz L; Reyes N; Aroche K; Tolosa V; Simanca V; Rogríguez T; Hardy E
J Pharm Pharm Sci; 2005 Aug; 8(2):207-16. PubMed ID: 16124932
[TBL] [Abstract][Full Text] [Related]
4. Some factors affecting the stability of interferon alpha 2b in solution.
Ruiz L; Reyes N; Aroche K; Báez R; Aldana R; Hardy E
Biologicals; 2006 Mar; 34(1):15-9. PubMed ID: 16188456
[TBL] [Abstract][Full Text] [Related]
5. Production, purification, and chemical stability of recombinant human interferon-γ in low oxygen tension condition: a formulation approach.
Malek-Sabet N; Masoumian MR; Zeinali M; Khalilzadeh R; Mousaabadi JM
Prep Biochem Biotechnol; 2013; 43(6):586-600. PubMed ID: 23742090
[TBL] [Abstract][Full Text] [Related]
6. Development of a high performance size exclusion chromatography method to determine the stability of Human Serum Albumin in a lyophilized formulation of Interferon alfa-2b.
Qian J; Tang Q; Cronin B; Markovich R; Rustum A
J Chromatogr A; 2008 Jun; 1194(1):48-56. PubMed ID: 18258245
[TBL] [Abstract][Full Text] [Related]
7. Hybrid (BDBB) interferon-alpha: preformulation studies.
Allen JD; Bentley D; Stringer RA; Lowther N
Int J Pharm; 1999 Oct; 187(2):259-72. PubMed ID: 10502632
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Biological Characterization of a Prepared Recombinant Human Interferon Alpha 2b Isoform.
Shaaban R; El-Sayed WM; Samir S; El-Dabaa E
Appl Biochem Biotechnol; 2019 May; 188(1):72-86. PubMed ID: 30334171
[TBL] [Abstract][Full Text] [Related]
9. Continuous release of Rh-interferon (alpha-2a from triglyceride implants: storage stability of the dosage forms.
Mohl S; Winter G
Pharm Dev Technol; 2006 Feb; 11(1):103-10. PubMed ID: 16544914
[TBL] [Abstract][Full Text] [Related]
10. A morphological screening of protein crystals for interferon delivery by metal ion-chelate technology.
Jiang Y; Shi K; Wang S; Li X; Cui F
Drug Dev Ind Pharm; 2010 Dec; 36(12):1389-97. PubMed ID: 21050135
[TBL] [Abstract][Full Text] [Related]
11. Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.
Braun A; Alsenz J
Pharm Res; 1997 Oct; 14(10):1394-400. PubMed ID: 9358552
[TBL] [Abstract][Full Text] [Related]
12. Stability of an extemporaneously prepared recombinant human interferon alfa-2b eye drop formulation.
Ruiz L; Rodriguez I; Baez R; Aldana R
Am J Health Syst Pharm; 2007 Aug; 64(16):1716-9. PubMed ID: 17687060
[TBL] [Abstract][Full Text] [Related]
13. Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature.
Larson B; Bushman LR; Casciano ML; Oldland AR; Kiser JJ; Kiser TH
Int J Pharm Compd; 2016; 20(6):521-525. PubMed ID: 28339392
[TBL] [Abstract][Full Text] [Related]
14. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
Ramon J; Saez V; Baez R; Aldana R; Hardy E
Pharm Res; 2005 Aug; 22(8):1374-86. PubMed ID: 16078148
[TBL] [Abstract][Full Text] [Related]
15. Protein spherulites for sustained release of interferon: preparation, characterization and in vivo evaluation.
Jiang Y; Shi K; Xia D; Wang S; Song T; Cui F
J Pharm Sci; 2011 May; 100(5):1913-22. PubMed ID: 21374623
[TBL] [Abstract][Full Text] [Related]
16. [Interferon alpha-2b modified with polyethylene glycol].
Wu Y; Zhai Y; Lei J; Ma G; Su Z
Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1658-63. PubMed ID: 19160853
[TBL] [Abstract][Full Text] [Related]
17. Influence of bovine serum albumin on the secondary structure of interferon alpha 2b as determined by far UV circular dichroism spectropolarimetry.
Johnston MJ; Nemr K; Hefford MA
Biologicals; 2010 Mar; 38(2):314-20. PubMed ID: 20031446
[TBL] [Abstract][Full Text] [Related]
18. Demonstrating the stability of albinterferon alfa-2b in the presence of silicone oil.
Auge KB; Blake-Haskins AW; Devine S; Rizvi S; Li YM; Hesselberg M; Orvisky E; Affleck RP; Spitznagel TM; Perkins MD
J Pharm Sci; 2011 Dec; 100(12):5100-14. PubMed ID: 21780119
[TBL] [Abstract][Full Text] [Related]
19. Aggregation of recombinant human interferon alpha 2b in solution: technical note.
Ruiz L; Aroche K; Reyes N
AAPS PharmSciTech; 2006; 7(4):99. PubMed ID: 17285753
[TBL] [Abstract][Full Text] [Related]
20. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
Kristensen S; Lao YE; Brustugun J; Braenden JU
Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
